Close Menu

NEW YORK – Ghent, Belgium-based MyCartis announced today that along with Ghent University it is spinning off a point-of-care testing business and forming a new firm, Antelope Dx.

MyCartis said that Ghent-based RMM and Gooik-based Saffelberg Investments have led the investment of €5.1 million ($5.7 million) in the new company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.